Nachrichten zur Pfizer Aktie

Pfizer RSV vaccine for older adults is only slightly less effective after 18 months

Pfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the…

UPDATE 1-US CDC advisers weigh use of GSK, Pfizer RSV vaccines in older adults

... (Reuters) - A panel of advisers to the U.S. Centers for Disease Control......…

US CDC advisers weigh use of GSK, Pfizer RSV vaccines in older adults

...(Reuters) - A panel of advisers to the U.S. Centers for Disease......…

Pfizer: FDA Approves Talzenna-Xtandi Combination To Treat Prostate Cancer

NEW YORK CITY (dpa-AFX) - Pfizer (PFE) said that the U.S. Food and Drug Administration has approved Talzenna (talazoparib), an…

Pfizer Gets FDA Approval to Treat Prostate Cancer With Talzenna, Xtandi

Pfizer Gets FDA Approval to Treat Prostate Cancer With Talzenna, Xtandi...…

Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start

The FDAs strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the…

Pfizer To Run Out Of Penicillin Solutions In Next Few Months

Pfizer To Run Out Of Penicillin Solutions In Next Few Months …

FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall

The FDAs decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of…

FDA advisors raise doubts about seasonal updates to Covid vaccines as with flu shots

The panels concerns push back against the FDAs proposed shift to annual Covid shots — an approach that vaccine makers…

Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support

Thursday, the FDA's Vaccines and Related Biological Products Advisory Committee all 21 members v read more...…

Drug And Food Shortages Are Here, And They Will Get A Lot Worse...

Drug And Food Shortages Are Here, And They Will Get A Lot Worse... …

Pfizer: Seagen-Übernahme im Fokus - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Pfizer: Schnelle Anpassung möglich

Der amerikanische Pharma-Gigant Pfizer verliert das Coronavirus nicht aus den Augen. Schließlich tauchen immer wieder neue Stämme auf, die angepasste…

Pfizer (PFE) Gains But Lags Market: What You Should Know

In the latest trading session, Pfizer (PFE) closed at $39.75, marking a +0.99% move from the previous day....…

Investment: Life-Sciences-Sektor ist resilient, aber nicht immun

Trotz einiger Megadeals von Pharmariesen wie Pfizer und Amgen waren die M&A-Aktivitäten in den Life Sciences im vergangenen Jahr insgesamt…

UPDATE 1-Pfizer expects to run out of some antibiotic supply for children soon

...(Adds details from Pfizer in paragraphs 1-4) June 13 (Reuters......…

Pfizer expects to run out of some antibiotic supply for children soon

...(Reuters) -Pfizer has warned that a drug used to treat syphilis......…

Fauci And Pfizer Lied To Trump About COVID-19 Vaccine, Claims Navarro

Fauci And Pfizer Lied To Trump About COVID-19 Vaccine, Claims Navarro …

Pfizer Sees Antibiotic Supply Running Out as Shortage Worsens

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer is running out of penicillin products amid supply constraints

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Updated Covid vaccines need to target XBB omicron variants this fall, FDA staff says

Vaccine manufacturers Pfizer, Moderna and Novavax will be expected to update their shots according to the strain the FDA selects…

Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now?

Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock…

Immix Biopharma Subsidiary Nexcella Appoints Henry McKinnell, Jr., former Chairman & CEO of Pfizer Inc., to Board of Directors

Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…

Prozess um Impfschäden gegen BioNTech verschoben

Hamburg (Reuters) - Die Verhandlung vor dem Landgericht Hamburg über eine Schadenersatzklage gegen das Biotechunternehmen BionTech wegen eines mutmaßlichen Corona-Impfschadens…

Corona-Impfstoffe: Weitere US-Firma reicht Patentklage gegen Biontech ein

Da will noch jemand ein Stück vom Milliardengeschäft: In den USA hat eine Biotechfirma Klage gegen Biontech, Pfizer und Moderna…

Seagen gains as antitrust deadline for Pfizer purchases nears on Monday

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioNTech: Neue Klage - Aktienanalyse

Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

BioNTech, Pfizer & Co: Neue Klage – das steckt dahinter

Die Impfstoffhersteller BioNTech, Pfizer und Moderna sehen sich einer neuen Klage gegenüber. Das Biotech-Unternehmen Promosome hat die Unternehmen verklagt. Der…

Pfizer (PFE) Gains But Lags Market: What You Should Know

Pfizer (PFE) closed at $39.09 in the latest trading session, marking a +0.51% move from the prior day....…

Samsung Biologics, Pfizer partner for biosimilars portfolio manufacturing

Initially, the companies signed a manufacturing agreement in March last year for a Pfizer product. As per the new agreement…

Samsung Biologics wins record Pfizer deal

Samsung Biologics said Thursday the company won a $411.3 million contract manufacturing deal from Pfizer to produce the US-based pharmaceutical…

Continued strong Cresemba® (isavuconazole) sales by Pfizer trigger USD 26 million sales milestone payments to Basilea

Ad hoc announcement pursuant to Art. 53 LR...…

Anhaltend starke Cresemba® (Isavuconazol)-Verkaufszahlen von Pfizer lösen Umsatzmeilensteinzahlungen in Höhe von USD 26 Mio. an Basilea aus

Ad hoc-Mitteilung gemäss Art. 53 KR...…

Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Diseases

Funding supports clinical development of first therapeutic candidate and pipeline expansion Marie-Claire Peakman, PhD, Partner, Pfizer Ventures, and Jasmina Marjanovic,…

dpa-AFX ProFeed